EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 33 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $672,317 | +1.7% | 66,566 | -0.2% | 0.02% | +31.2% |
| Q3 2022 | $661,000 | +1.2% | 66,666 | 0.0% | 0.02% | +6.7% |
| Q2 2022 | $653,000 | +0.3% | 66,666 | 0.0% | 0.02% | 0.0% |
| Q1 2022 | $651,000 | +0.6% | 66,666 | 0.0% | 0.02% | -11.8% |
| Q4 2021 | $647,000 | -0.3% | 66,666 | 0.0% | 0.02% | -10.5% |
| Q3 2021 | $649,000 | +0.3% | 66,666 | 0.0% | 0.02% | -5.0% |
| Q2 2021 | $647,000 | – | 66,666 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |